Exelixis, Inc. (EXEL)
52.99
+1.25
(+2.42%)
USD |
NASDAQ |
Jun 09, 16:00
53.50
+0.51
(+0.96%)
After-Hours: 20:00
Exelixis EPS Diluted (TTM) : 3.017 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Merck & Co., Inc. | 3.553 |
| Catalyst Pharmaceuticals, Inc. | 1.740 |
| Madrigal Pharmaceuticals, Inc. | -12.80 |
| Krystal Biotech, Inc. | 7.482 |
| ACADIA Pharmaceuticals, Inc. | 2.196 |